Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c07c34f6d167d5ae87a32a0feda9912 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-42 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-13 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C11-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C11-00 |
filingDate |
2012-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb33a25ae877b7b19dc6a88e0c35e454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c13969caf6f69b0794b820ac1fed0fde http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0673c5d065c79a2d4e24521daabb956 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2de83d14a9da5c2812b0eb00b08ab038 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4db2b47fbac0452a9ddd9d0a66070d54 |
publicationDate |
2018-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3279211-A1 |
titleOfInvention |
Unnatural amino acids comprising a norbornenyl group and uses thereof |
abstract |
The present invention relates to unnatural amino acids comprising a norbornenyl group and having formulan nor an acid or base addition salt thereof. n The invention also relates to the use of said unnatural amino acids and processes for preparation of polypeptides that comprise one or more than one norbornenyl group. These polypeptides can be covalently modified by in vitro or in vivo reaction with compounds comprising a 1,2,4,5-tetrazine group. |
priorityDate |
2011-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |